nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00259	CcSEcCtD
Amantadine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00258	CcSEcCtD
Amantadine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00258	CcSEcCtD
Amantadine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00258	CcSEcCtD
Amantadine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.0021	0.00257	CcSEcCtD
Amantadine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.0021	0.00257	CcSEcCtD
Amantadine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.00257	CcSEcCtD
Amantadine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00208	0.00255	CcSEcCtD
Amantadine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00255	CcSEcCtD
Amantadine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00253	CcSEcCtD
Amantadine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00253	CcSEcCtD
Amantadine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00253	CcSEcCtD
Amantadine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00206	0.00252	CcSEcCtD
Amantadine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00252	CcSEcCtD
Amantadine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00252	CcSEcCtD
Amantadine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00251	CcSEcCtD
Amantadine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00249	CcSEcCtD
Amantadine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00249	CcSEcCtD
Amantadine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.00249	CcSEcCtD
Amantadine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00249	CcSEcCtD
Amantadine—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00201	0.00246	CcSEcCtD
Amantadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.002	0.00245	CcSEcCtD
Amantadine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00244	CcSEcCtD
Amantadine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00199	0.00244	CcSEcCtD
Amantadine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00242	CcSEcCtD
Amantadine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00242	CcSEcCtD
Amantadine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00197	0.0024	CcSEcCtD
Amantadine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.0024	CcSEcCtD
Amantadine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.00239	CcSEcCtD
Amantadine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00238	CcSEcCtD
Amantadine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00236	CcSEcCtD
Amantadine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00236	CcSEcCtD
Amantadine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00236	CcSEcCtD
Amantadine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00235	CcSEcCtD
Amantadine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00235	CcSEcCtD
Amantadine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00233	CcSEcCtD
Amantadine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00231	CcSEcCtD
Amantadine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00231	CcSEcCtD
Amantadine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.00229	CcSEcCtD
Amantadine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00227	CcSEcCtD
Amantadine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00227	CcSEcCtD
Amantadine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00227	CcSEcCtD
Amantadine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00183	0.00224	CcSEcCtD
Amantadine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00223	CcSEcCtD
Amantadine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00222	CcSEcCtD
Amantadine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00222	CcSEcCtD
Amantadine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00222	CcSEcCtD
Amantadine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00222	CcSEcCtD
Amantadine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00179	0.0022	CcSEcCtD
Amantadine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00218	CcSEcCtD
Amantadine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00218	CcSEcCtD
Amantadine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00218	CcSEcCtD
Amantadine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00218	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00217	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00217	CcSEcCtD
Amantadine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00214	CcSEcCtD
Amantadine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00214	CcSEcCtD
Amantadine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00214	CcSEcCtD
Amantadine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00213	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00213	CcSEcCtD
Amantadine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00209	CcSEcCtD
Amantadine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00209	CcSEcCtD
Amantadine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00209	CcSEcCtD
Amantadine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00209	CcSEcCtD
Amantadine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00209	CcSEcCtD
Amantadine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00206	CcSEcCtD
Amantadine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00206	CcSEcCtD
Amantadine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00205	CcSEcCtD
Amantadine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00205	CcSEcCtD
Amantadine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00205	CcSEcCtD
Amantadine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00205	CcSEcCtD
Amantadine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00204	CcSEcCtD
Amantadine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00204	CcSEcCtD
Amantadine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00203	CcSEcCtD
Amantadine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00203	CcSEcCtD
Amantadine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00166	0.00203	CcSEcCtD
Amantadine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00202	CcSEcCtD
Amantadine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00202	CcSEcCtD
Amantadine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00201	CcSEcCtD
Amantadine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00199	CcSEcCtD
Amantadine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00199	CcSEcCtD
Amantadine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00198	CcSEcCtD
Amantadine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00198	CcSEcCtD
Amantadine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00196	CcSEcCtD
Amantadine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00196	CcSEcCtD
Amantadine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00195	CcSEcCtD
Amantadine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00194	CcSEcCtD
Amantadine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00194	CcSEcCtD
Amantadine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00193	CcSEcCtD
Amantadine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00192	CcSEcCtD
Amantadine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00191	CcSEcCtD
Amantadine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00191	CcSEcCtD
Amantadine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00189	CcSEcCtD
Amantadine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00189	CcSEcCtD
Amantadine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00189	CcSEcCtD
Amantadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00188	CcSEcCtD
Amantadine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00187	CcSEcCtD
Amantadine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00187	CcSEcCtD
Amantadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00186	CcSEcCtD
Amantadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00186	CcSEcCtD
Amantadine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00186	CcSEcCtD
Amantadine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00185	CcSEcCtD
Amantadine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00185	CcSEcCtD
Amantadine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00184	CcSEcCtD
Amantadine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00184	CcSEcCtD
Amantadine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00184	CcSEcCtD
Amantadine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00184	CcSEcCtD
Amantadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00182	CcSEcCtD
Amantadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00182	CcSEcCtD
Amantadine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00181	CcSEcCtD
Amantadine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00181	CcSEcCtD
Amantadine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00181	CcSEcCtD
Amantadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00181	CcSEcCtD
Amantadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00181	CcSEcCtD
Amantadine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00179	CcSEcCtD
Amantadine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00179	CcSEcCtD
Amantadine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00179	CcSEcCtD
Amantadine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00179	CcSEcCtD
Amantadine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00178	CcSEcCtD
Amantadine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00177	CcSEcCtD
Amantadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00177	CcSEcCtD
Amantadine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00176	CcSEcCtD
Amantadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00176	CcSEcCtD
Amantadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00175	CcSEcCtD
Amantadine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00174	CcSEcCtD
Amantadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00174	CcSEcCtD
Amantadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00173	CcSEcCtD
Amantadine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00173	CcSEcCtD
Amantadine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00173	CcSEcCtD
Amantadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00172	CcSEcCtD
Amantadine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00172	CcSEcCtD
Amantadine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00172	CcSEcCtD
Amantadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00172	CcSEcCtD
Amantadine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00171	CcSEcCtD
Amantadine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00171	CcSEcCtD
Amantadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00171	CcSEcCtD
Amantadine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00169	CcSEcCtD
Amantadine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00168	CcSEcCtD
Amantadine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00166	CcSEcCtD
Amantadine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00166	CcSEcCtD
Amantadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00165	CcSEcCtD
Amantadine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00164	CcSEcCtD
Amantadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00164	CcSEcCtD
Amantadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00164	CcSEcCtD
Amantadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00164	CcSEcCtD
Amantadine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00163	CcSEcCtD
Amantadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00163	CcSEcCtD
Amantadine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00162	CcSEcCtD
Amantadine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00131	0.0016	CcSEcCtD
Amantadine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.0013	0.0016	CcSEcCtD
Amantadine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00156	CcSEcCtD
Amantadine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00154	CcSEcCtD
Amantadine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00154	CcSEcCtD
Amantadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00154	CcSEcCtD
Amantadine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00154	CcSEcCtD
Amantadine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00151	CcSEcCtD
Amantadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.0015	CcSEcCtD
Amantadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00123	0.0015	CcSEcCtD
Amantadine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00148	CcSEcCtD
Amantadine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00148	CcSEcCtD
Amantadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00147	CcSEcCtD
Amantadine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00146	CcSEcCtD
Amantadine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00145	CcSEcCtD
Amantadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00143	CcSEcCtD
Amantadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00143	CcSEcCtD
Amantadine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00143	CcSEcCtD
Amantadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00142	CcSEcCtD
Amantadine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00141	CcSEcCtD
Amantadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00115	0.0014	CcSEcCtD
Amantadine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0014	CcSEcCtD
Amantadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00139	CcSEcCtD
Amantadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00139	CcSEcCtD
Amantadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00136	CcSEcCtD
Amantadine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00136	CcSEcCtD
Amantadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00135	CcSEcCtD
Amantadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00133	CcSEcCtD
Amantadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00133	CcSEcCtD
Amantadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00132	CcSEcCtD
Amantadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00132	CcSEcCtD
Amantadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00132	CcSEcCtD
Amantadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00132	CcSEcCtD
Amantadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00131	CcSEcCtD
Amantadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00131	CcSEcCtD
Amantadine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00131	CcSEcCtD
Amantadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00131	CcSEcCtD
Amantadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00107	0.0013	CcSEcCtD
Amantadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00129	CcSEcCtD
Amantadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00129	CcSEcCtD
Amantadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00129	CcSEcCtD
Amantadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00126	CcSEcCtD
Amantadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00125	CcSEcCtD
Amantadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00125	CcSEcCtD
Amantadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00124	CcSEcCtD
Amantadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00124	CcSEcCtD
Amantadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00124	CcSEcCtD
Amantadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000996	0.00122	CcSEcCtD
Amantadine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000985	0.0012	CcSEcCtD
Amantadine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000981	0.0012	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000964	0.00528	CbGpPWpGaD
Amantadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000961	0.00117	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.00096	0.00526	CbGpPWpGaD
Amantadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00096	0.00526	CbGpPWpGaD
Amantadine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000944	0.00115	CcSEcCtD
Amantadine—GRIN1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000934	0.00512	CbGpPWpGaD
Amantadine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000928	0.00113	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000928	0.00113	CcSEcCtD
Amantadine—GRIN2B—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00091	0.00499	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000906	0.00496	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000905	0.00496	CbGpPWpGaD
Amantadine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000905	0.00111	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000897	0.0011	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000891	0.00488	CbGpPWpGaD
Amantadine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000887	0.00108	CcSEcCtD
Amantadine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000861	0.00105	CcSEcCtD
Amantadine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000847	0.00104	CcSEcCtD
Amantadine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000839	0.00103	CcSEcCtD
Amantadine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000838	0.00103	CcSEcCtD
Amantadine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000833	0.00102	CcSEcCtD
Amantadine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000831	0.00102	CcSEcCtD
Amantadine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000826	0.00101	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000794	0.00435	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000789	0.00432	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000788	0.00432	CbGpPWpGaD
Amantadine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000778	0.000952	CcSEcCtD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000777	0.00426	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000772	0.00423	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000766	0.0042	CbGpPWpGaD
Amantadine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000764	0.000935	CcSEcCtD
Amantadine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000759	0.000928	CcSEcCtD
Amantadine—MAOB—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000755	0.00414	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000754	0.00413	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000735	0.00403	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000734	0.00402	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000724	0.00397	CbGpPWpGaD
Amantadine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000716	0.000875	CcSEcCtD
Amantadine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000713	0.000872	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000701	0.00384	CbGpPWpGaD
Amantadine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000701	0.000857	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000698	0.000854	CcSEcCtD
Amantadine—MAOB—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000694	0.0038	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000692	0.00379	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000686	0.00376	CbGpPWpGaD
Amantadine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000683	0.000836	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000678	0.00371	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000675	0.0037	CbGpPWpGaD
Amantadine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000674	0.000824	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000674	0.000824	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000665	0.00364	CbGpPWpGaD
Amantadine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000661	0.000809	CcSEcCtD
Amantadine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000658	0.000805	CcSEcCtD
Amantadine—MAOB—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000658	0.0036	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000656	0.00359	CbGpPWpGaD
Amantadine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000655	0.000801	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000652	0.000797	CcSEcCtD
Amantadine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000642	0.000786	CcSEcCtD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000633	0.00347	CbGpPWpGaD
Amantadine—DDC—Metabolism—APIP—chronic obstructive pulmonary disease	0.000629	0.00344	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000618	0.00339	CbGpPWpGaD
Amantadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000613	0.00075	CcSEcCtD
Amantadine—SLC22A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000611	0.00335	CbGpPWpGaD
Amantadine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00061	0.000746	CcSEcCtD
Amantadine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000605	0.00074	CcSEcCtD
Amantadine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000599	0.00328	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000599	0.00328	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000595	0.00326	CbGpPWpGaD
Amantadine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000593	0.000726	CcSEcCtD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00059	0.00324	CbGpPWpGaD
Amantadine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000586	0.000717	CcSEcCtD
Amantadine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000585	0.000715	CcSEcCtD
Amantadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000584	0.000715	CcSEcCtD
Amantadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000581	0.000711	CcSEcCtD
Amantadine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000581	0.000711	CcSEcCtD
Amantadine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000576	0.000705	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000576	0.00316	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000568	0.00311	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000558	0.00306	CbGpPWpGaD
Amantadine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000555	0.000679	CcSEcCtD
Amantadine—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000555	0.00304	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000554	0.00303	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000551	0.00302	CbGpPWpGaD
Amantadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.000674	CcSEcCtD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000546	0.00299	CbGpPWpGaD
Amantadine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000533	0.000652	CcSEcCtD
Amantadine—MAOB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000529	0.0029	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000523	0.00287	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.00051	0.00279	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000508	0.00278	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000502	0.00275	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000502	0.00275	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000497	0.00272	CbGpPWpGaD
Amantadine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000497	0.000607	CcSEcCtD
Amantadine—GRIN2B—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.00049	0.00268	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000487	0.00267	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000485	0.00266	CbGpPWpGaD
Amantadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000484	0.000592	CcSEcCtD
Amantadine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000583	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000473	0.00259	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.00047	0.00257	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000468	0.00256	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000465	0.00255	CbGpPWpGaD
Amantadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000564	CcSEcCtD
Amantadine—DRD2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000457	0.0025	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000452	0.00248	CbGpPWpGaD
Amantadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000545	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000443	0.00243	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000438	0.0024	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000432	0.00237	CbGpPWpGaD
Amantadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000429	0.000524	CcSEcCtD
Amantadine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00052	CcSEcCtD
Amantadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000519	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000424	0.00232	CbGpPWpGaD
Amantadine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000516	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000419	0.00229	CbGpPWpGaD
Amantadine—DDC—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000416	0.00228	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000414	0.00227	CbGpPWpGaD
Amantadine—DDC—Metabolism—GC—chronic obstructive pulmonary disease	0.000405	0.00222	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000403	0.00221	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000402	0.0022	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000402	0.0022	CbGpPWpGaD
Amantadine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00049	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000396	0.00217	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000393	0.00215	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.00039	0.00214	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000383	0.0021	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00038	0.00208	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000379	0.00207	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000377	0.00206	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000375	0.00205	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000364	0.002	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000363	0.00199	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000358	0.00196	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000356	0.00195	CbGpPWpGaD
Amantadine—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000351	0.00192	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	0.000341	0.00187	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.00034	0.00186	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000339	0.00186	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000332	0.00182	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000321	0.00176	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000317	0.00174	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000294	0.00161	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000291	0.0016	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000281	0.00154	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000279	0.00153	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000277	0.00152	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000274	0.0015	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000266	0.00146	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000262	0.00143	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000251	0.00137	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000244	0.00134	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000244	0.00134	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000236	0.00129	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000235	0.00129	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000228	0.00125	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000227	0.00124	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000224	0.00122	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000221	0.00121	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.00022	0.00121	CbGpPWpGaD
Amantadine—DDC—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000219	0.0012	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000211	0.00116	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000208	0.00114	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000206	0.00113	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000205	0.00112	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000204	0.00112	CbGpPWpGaD
Amantadine—DDC—Metabolism—CTGF—chronic obstructive pulmonary disease	0.0002	0.00109	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000197	0.00108	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000194	0.00106	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000192	0.00105	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.00019	0.00104	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000186	0.00102	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000186	0.00102	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000185	0.00101	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000185	0.00101	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000184	0.00101	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.00101	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	0.000181	0.000992	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000178	0.000976	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000176	0.000965	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000174	0.000951	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.00095	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000171	0.000934	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00017	0.000934	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000169	0.000924	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000168	0.000922	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000168	0.000921	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000166	0.000912	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000166	0.000911	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000159	0.000871	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000157	0.000859	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000156	0.000857	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000155	0.00085	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.000848	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000153	0.000841	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000153	0.000841	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000153	0.000837	CbGpPWpGaD
Amantadine—DDC—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000151	0.000829	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000151	0.000825	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000147	0.000804	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000144	0.000791	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000143	0.000782	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000142	0.000778	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000141	0.000772	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000138	0.000758	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000137	0.000752	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000136	0.000743	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000135	0.000741	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000134	0.000737	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.000732	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000132	0.000722	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000131	0.000718	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000129	0.000708	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000128	0.0007	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000127	0.000698	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000124	0.00068	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000122	0.000667	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000121	0.000663	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000119	0.00065	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000119	0.00065	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000116	0.000635	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000113	0.000619	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000616	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00011	0.000603	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000104	0.00057	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000102	0.000557	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.89e-05	0.000542	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	9.89e-05	0.000542	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.81e-05	0.000537	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.77e-05	0.000535	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.63e-05	0.000527	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.35e-05	0.000512	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.21e-05	0.000505	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.19e-05	0.000504	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.12e-05	0.0005	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.11e-05	0.000499	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALB—chronic obstructive pulmonary disease	9.08e-05	0.000498	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.92e-05	0.000489	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.9e-05	0.000488	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.81e-05	0.000483	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.76e-05	0.00048	CbGpPWpGaD
Amantadine—DDC—Metabolism—NOS3—chronic obstructive pulmonary disease	8.69e-05	0.000476	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.66e-05	0.000475	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.39e-05	0.000459	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.38e-05	0.000459	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.31e-05	0.000455	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.22e-05	0.00045	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.21e-05	0.00045	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.07e-05	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.96e-05	0.000436	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.88e-05	0.000432	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.67e-05	0.00042	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.66e-05	0.00042	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	7.65e-05	0.000419	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.54e-05	0.000413	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.39e-05	0.000405	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	7.31e-05	0.000401	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.04e-05	0.000386	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.96e-05	0.000381	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.85e-05	0.000375	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.76e-05	0.00037	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00035	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.3e-05	0.000345	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.3e-05	0.000345	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.21e-05	0.00034	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.13e-05	0.000336	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.97e-05	0.000327	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.000322	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.7e-05	0.000312	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.000305	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.4e-05	0.000296	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.34e-05	0.000293	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.26e-05	0.000288	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.87e-05	0.000267	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.74e-05	0.00026	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.73e-05	0.000259	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.7e-05	0.000258	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.49e-05	0.000246	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.3e-05	0.000236	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.27e-05	0.000234	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.11e-05	0.000225	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-05	0.000222	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.88e-05	0.000213	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.82e-05	0.000209	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.78e-05	0.000207	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.000205	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.69e-05	0.000202	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.62e-05	0.000198	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000188	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000179	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000172	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3e-05	0.000164	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.86e-05	0.000157	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.54e-05	0.000139	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000132	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.3e-05	0.000126	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000121	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.12e-05	0.000116	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.06e-05	0.000113	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.89e-05	0.000104	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.000102	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.56e-05	8.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.43e-05	7.82e-05	CbGpPWpGaD
